Kornitzer Capital Management Inc. KS Has $12.57 Million Holdings in Xylem Inc. (NYSE:XYL)

Kornitzer Capital Management Inc. KS boosted its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 9.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 109,882 shares of the industrial products company’s stock after acquiring an additional 9,114 shares during the quarter. Kornitzer Capital Management Inc. KS’s holdings in Xylem were worth $12,566,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of XYL. International Assets Investment Management LLC raised its stake in shares of Xylem by 10,296.7% during the 4th quarter. International Assets Investment Management LLC now owns 63,004 shares of the industrial products company’s stock worth $7,205,000 after purchasing an additional 62,398 shares in the last quarter. ING Groep NV purchased a new stake in shares of Xylem during the 3rd quarter worth about $2,752,000. Meiji Yasuda Asset Management Co Ltd. raised its stake in shares of Xylem by 6.6% during the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 39,266 shares of the industrial products company’s stock worth $3,574,000 after purchasing an additional 2,438 shares in the last quarter. SG Americas Securities LLC raised its stake in shares of Xylem by 351.2% during the 4th quarter. SG Americas Securities LLC now owns 101,408 shares of the industrial products company’s stock worth $11,597,000 after purchasing an additional 78,934 shares in the last quarter. Finally, Mariner LLC raised its stake in shares of Xylem by 10.3% during the 3rd quarter. Mariner LLC now owns 75,036 shares of the industrial products company’s stock worth $6,831,000 after purchasing an additional 7,006 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Stock Performance

NYSE XYL traded up $0.68 during trading on Friday, hitting $127.84. The company’s stock had a trading volume of 2,250,015 shares, compared to its average volume of 921,680. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The firm has a 50 day moving average price of $127.01 and a 200 day moving average price of $112.36. The firm has a market cap of $30.99 billion, a P/E ratio of 47.00, a price-to-earnings-growth ratio of 2.53 and a beta of 1.10. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $130.86.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same period in the previous year, the business posted $0.92 EPS. The company’s revenue for the quarter was up 40.6% on a year-over-year basis. Equities research analysts forecast that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.13%. The ex-dividend date was Tuesday, February 20th. This is a positive change from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio (DPR) is presently 52.94%.

Insider Transactions at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on XYL shares. Oppenheimer raised their price target on Xylem from $133.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday. Raymond James raised Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Citigroup raised their price objective on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research note on Monday, April 8th. Stifel Nicolaus raised their price objective on Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. Finally, BNP Paribas started coverage on Xylem in a research note on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and a consensus target price of $138.11.

Get Our Latest Stock Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.